Status:
RECRUITING
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Conditions:
Prostate Cancer
Kidney Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This prospective study will compare pre-post pilot test of surgeon-facing, visual decision support among urologists seeing patients with newly diagnosed localized prostate and kidney cancer. Up to 20 ...
Eligibility Criteria
Inclusion
- In order to participate in this study, a subject must meet all of the eligibility criteria outlined below.
- Verbal informed consent was obtained to participate in the study.
- Subject is willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
- Age ≥ 18 years at the time of consent.
- For patient subjects, HIPAA authorization for the release of personal health information and a new histologic diagnosis of localized prostate cancer based on prostate biopsy or clinical diagnosis of T1 renal mass (≤7 cm in diameter) Suspicion for kidney cancer based on cross-sectional imaging. New diagnosis is defined as within 6 months of consent. T1 renal masses include solid masses or Bosniak III/IV cystic masses.
- For physician subjects, practicing urologist in North Carolina at UNC Health, Novant Health, or an affiliated site and sees patients with suspected or confirmed prostate or kidney cancer.
Exclusion
- The subjects meeting the following criteria will be excluded from study participation:
- Non-English speaking.
- Unwilling or unable to complete informed consent.
- For patient subjects:
- Has staging information indicating locally advanced or metastatic disease. This would include PSA \>50 ng/ml, imaging suggestive of distant metastasis, or lymph node involvement, renal masses \>7 cm or invading in renal sinus or tumor thrombus.
- Histologic or clinical diagnosis \>6 months before date of consent.
Key Trial Info
Start Date :
April 24 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2028
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT06965192
Start Date
April 24 2025
End Date
January 30 2028
Last Update
December 5 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States, 27599
2
New Hanover Regional Medical Center
Wilmington, North Carolina, United States, 28401